LPIN1 and prostate carcinoma: The alterations in lipin-1, -2 and -3 expression in prostate cancer patients, and correlation between lipin-1 expression and PA and DAG in some select cell lines, suggest that these enzymes may regulate lipid levels in prostate cancer.